Top

Published in:

01-11-2019 | Hypertension | Capsule Commentary

Capsule Commentary: Mehta et al. Electronic Pill Bottles or Bidirectional Text Messaging to Improve Hypertension Medication Adherence

Author: Paul Sorum, MD, PhD

Published in: Journal of General Internal Medicine | Issue 11/2019

Excerpt

Mehta and colleagues¹ performed a randomized controlled trial of the impact on inadequately controlled blood pressures of two technological interventions to improve medication adherence.^2‐4 They compared usual care to electronic pill bottles that notified the study’s electronic platform when the patients opened them and to bidirectional text messaging from the platform that asked the patients to text back if they took the medication. The patients of both intervention groups received messages each day reporting on the previous day and reminding them to take their medications. Neither intervention lowered systolic blood pressures at 4 months more than did usual care. …

Mehta SJ, Volpp KG, Troxel AB, Day SC, Lim R, Marcus N, Norton L, Anderson S, Asch DA. Electronic pill bottles or bidirectional text messaging to improve hypertension medication adherence (Way 2 Text): A randomized clinical trial. J Gen Intern Med 2019 https://doi.org/10.1007/11606.1525-1497

van Onzenoort HA, Verberk WJ, Kessels AG, Kroon AA, Neef C, van der Kuy PH, de Leeuw PW. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. Am J Hypertens 2010;23(2):149–54.CrossRef

Thakkar J, Kurup R, Laba T-LO, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 2016;176(3):340–9.CrossRef

Kessler JB, Troxel AB, Asch DA, Mehta SJ, Marcus N, Um R, Zhu J, Shrank W, Brennan T, Volpp KG. Partners and alerts in medication adherence: a randomized clinical trial. J Gen Intern Med 2018;33(9):1536–42.CrossRef

van Heuckelum M, van den Ende CHM, Houterman AEJ, Hemmskerk CPM, van Dulmen S, van den Bemt BJF. The effect of electronic monitoring feedback on medication adherence and clinical outcomes: A systematic review. PLOS ONE 2017;12(10): e0185463 https://doi.org/10.1371/journal.pone.0185453.CrossRef

Title: Capsule Commentary: Mehta et al. Electronic Pill Bottles or Bidirectional Text Messaging to Improve Hypertension Medication Adherence
Author: Paul Sorum, MD, PhD
Publication date: 01-11-2019
Publisher: Springer US
Keywords: Hypertension
Hypertension
Published in: Journal of General Internal Medicine / Issue 11/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05280-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Capsule Commentary: Mehta et al. Electronic Pill Bottles or Bidirectional Text Messaging to Improve Hypertension Medication Adherence

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2019

Sexual Orientation and Patient-Provider Communication About Sexual Problems or Concerns Among US Adults

“You Guys Really Care About Me…”: a Qualitative Exploration of a Produce Prescription Program in Safety Net Clinics

Orbital Cellulitis with Subperiosteal Abscess (with Video)

Predicting Outcomes of In-Hospital Cardiac Arrest: Retrospective US Validation of the Good Outcome Following Attempted Resuscitation Score

Reproducibility in the Assessment of the Components of a Clinical Complexity Index

Evaluation of Physician Network-Based Measures of Care Coordination Using Medicare Patient-Reported Experience Measures

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page